Category: Corporate Crime

WASHINGTON D.C. – The Federal Trade Commission is cracking down on alleged anti-competitive practices, with a recent statement highlighting concerns over the case of FTC v. Surescripts. While the details remain shrouded in legal jargon, sources within the FTC suggest a deliberate attempt to stifle competition through manipulative loyalty discounts – a tactic increasingly common…

NEW YORK, NY – The Federal Trade Commission is taking aim at StubHub Holdings, Inc., alleging the ticket giant engaged in a calculated scheme to strangle competition and solidify its dominance over the secondary ticket market. Chairman Andrew N. Ferguson delivered a scathing statement today, detailing how StubHub leveraged its market position to effectively box…

WASHINGTON D.C. – The Federal Trade Commission is sending a clear message to corporate America: loyalty programs aren’t shields against antitrust scrutiny. Chairman Andrew N. Ferguson, along with Commissioner Mark R. Meador, issued a scathing concurring statement in the matter of Walmart Spark Driver, effectively highlighting a disturbing trend of anti-competitive practices disguised as consumer…

WASHINGTON D.C. – The Federal Trade Commission is sending a clear message to corporate America: loyalty discounts aren’t a loophole for stifling competition. Commissioner Mark R. Meador issued a scathing statement today detailing concerns surrounding the anti-competitive practices of Synopsys, Inc. and Ansys, Inc., signaling a potential crackdown on how these tech giants maintain their…

WASHINGTON D.C. – Philip Serpe is facing the heat from the Federal Trade Commission, accused of orchestrating a scheme to stifle competition within the critical prescription drug information network. The FTC alleges Serpe, through his actions, actively worked to maintain a monopoly, ultimately harming pharmacies, insurers, and patients across the nation. This isn’t a back-alley…

WASHINGTON D.C. – Craig Lewis is facing the music after the Federal Trade Commission exposed a calculated scheme to stifle competition within the prescription drug industry. The FTC alleges Lewis, through his actions, leveraged market dominance to crush smaller rivals, ultimately harming consumers and threatening the integrity of a vital healthcare network. This isn’t just…

WASHINGTON D.C. – The Federal Trade Commission is locked in a legal battle with Matthew Chesnes, accused of orchestrating a scheme to stifle competition within the crucial prescription drug information network. While the details remain shrouded in legal maneuvering – petitions to *quash* evidence, specifically – sources within the FTC suggest Chesnes’ actions, while appearing…

WASHINGTON D.C. – Eusabio Juarez-Ruffino is facing serious allegations of anti-competitive behavior, according to a recent Federal Trade Commission filing. The FTC alleges Juarez-Ruffino engaged in practices designed to stifle competition within a critical healthcare network, potentially impacting patient access and driving up costs. This isn’t some back-alley shakedown; this is a calculated scheme executed…

WASHINGTON D.C. – The Federal Trade Commission is taking aim at alleged anti-competitive behavior within the healthcare tech sector, specifically targeting Matthew Chesnes and the practices surrounding Surescripts. While details remain shrouded in legal maneuvering – a petition to quash filed by The Endocrine Society is currently under review – sources within the FTC suggest…

WASHINGTON D.C. – The Federal Trade Commission is cracking down on EQT Corporation, alleging the private equity behemoth engaged in anti-competitive practices designed to stifle innovation and maintain a stranglehold on the prescription drug information market. The FTC’s complaint, unsealed today, details how EQT, through its subsidiary QEP Partners, allegedly used predatory loyalty discounts to…